Passage Bio Inc. (NASDAQ: PASG) Stock Information | RedChip

Passage Bio Inc. (NASDAQ: PASG) Listen to this Section


$0.77
-0.0104 ( -1.33% ) 99.6K

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Market Data


Open


$0.77

Previous close


$0.78

Volume


99.6K

Market cap


$47.12M

Day range


$0.76 - $0.81

52 week range


$0.58 - $1.79

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Dec 29, 2023
8-k 8K-related 14 Dec 20, 2023
10-q Quarterly Reports 64 Nov 13, 2023
8-k 8K-related 45 Nov 13, 2023
8-k 8K-related 12 Sep 01, 2023
10-q Quarterly Reports 61 Aug 07, 2023
8-k 8K-related 41 Aug 07, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.